Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature

Uterine leiomyosarcoma (uLMS) is a rare and aggressive cancer, usually diagnosed incidentally at the time of myomectomy or hysterectomy. There have been concerns for several years about the fact that the inadvertent disruption of occult uLMS may have a negative impact on patient outcome. This study...

Full description

Bibliographic Details
Main Authors: Tanitra Tantitamit, Kuan-Gen Huang, Manatsawee Manopunya, Chih-Feng Yen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Gynecology and Minimally Invasive Therapy
Subjects:
Online Access:http://www.e-gmit.com/article.asp?issn=2213-3070;year=2018;volume=7;issue=2;spage=47;epage=55;aulast=Tantitamit
_version_ 1811245350579601408
author Tanitra Tantitamit
Kuan-Gen Huang
Manatsawee Manopunya
Chih-Feng Yen
author_facet Tanitra Tantitamit
Kuan-Gen Huang
Manatsawee Manopunya
Chih-Feng Yen
author_sort Tanitra Tantitamit
collection DOAJ
description Uterine leiomyosarcoma (uLMS) is a rare and aggressive cancer, usually diagnosed incidentally at the time of myomectomy or hysterectomy. There have been concerns for several years about the fact that the inadvertent disruption of occult uLMS may have a negative impact on patient outcome. This study reviews the outcome and management of patients with a diagnosis of uLMS after surgery for presumed benign disease. We conducted a literature search in which 47 published English-language articles were obtained for evaluation. A total of 23 studies with outcomes data were included. It is evidenced that patients who underwent surgery with tumor disruption resulted in poorer outcomes compared with en bloc tumor, especially by power morcellation. The power morcellation was associated with an increased risk of recurrence, shorten time to recurrence, and upstage after re-exploration. Early re-exploration and surgical staging are appreciated for better prognosis and may alter postoperative treatment. We also updated on the incidence and preoperative evaluation to assess the risk of patient and give an effective counseling.
first_indexed 2024-04-12T14:38:00Z
format Article
id doaj.art-470ba09be22a482f9cc0e74d801db7fe
institution Directory Open Access Journal
issn 2213-3070
language English
last_indexed 2024-04-12T14:38:00Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Gynecology and Minimally Invasive Therapy
spelling doaj.art-470ba09be22a482f9cc0e74d801db7fe2022-12-22T03:28:59ZengWolters Kluwer Medknow PublicationsGynecology and Minimally Invasive Therapy2213-30702018-01-0172475510.4103/GMIT.GMIT_10_18Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literatureTanitra TantitamitKuan-Gen HuangManatsawee ManopunyaChih-Feng YenUterine leiomyosarcoma (uLMS) is a rare and aggressive cancer, usually diagnosed incidentally at the time of myomectomy or hysterectomy. There have been concerns for several years about the fact that the inadvertent disruption of occult uLMS may have a negative impact on patient outcome. This study reviews the outcome and management of patients with a diagnosis of uLMS after surgery for presumed benign disease. We conducted a literature search in which 47 published English-language articles were obtained for evaluation. A total of 23 studies with outcomes data were included. It is evidenced that patients who underwent surgery with tumor disruption resulted in poorer outcomes compared with en bloc tumor, especially by power morcellation. The power morcellation was associated with an increased risk of recurrence, shorten time to recurrence, and upstage after re-exploration. Early re-exploration and surgical staging are appreciated for better prognosis and may alter postoperative treatment. We also updated on the incidence and preoperative evaluation to assess the risk of patient and give an effective counseling.http://www.e-gmit.com/article.asp?issn=2213-3070;year=2018;volume=7;issue=2;spage=47;epage=55;aulast=TantitamitHysterectomymyomectomyoccult leiomyosarcomaprognosis
spellingShingle Tanitra Tantitamit
Kuan-Gen Huang
Manatsawee Manopunya
Chih-Feng Yen
Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature
Gynecology and Minimally Invasive Therapy
Hysterectomy
myomectomy
occult leiomyosarcoma
prognosis
title Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature
title_full Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature
title_fullStr Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature
title_full_unstemmed Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature
title_short Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: Review of literature
title_sort outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease review of literature
topic Hysterectomy
myomectomy
occult leiomyosarcoma
prognosis
url http://www.e-gmit.com/article.asp?issn=2213-3070;year=2018;volume=7;issue=2;spage=47;epage=55;aulast=Tantitamit
work_keys_str_mv AT tanitratantitamit outcomeandmanagementofuterineleiomyosarcomatreatedfollowingsurgeryforpresumedbenigndiseasereviewofliterature
AT kuangenhuang outcomeandmanagementofuterineleiomyosarcomatreatedfollowingsurgeryforpresumedbenigndiseasereviewofliterature
AT manatsaweemanopunya outcomeandmanagementofuterineleiomyosarcomatreatedfollowingsurgeryforpresumedbenigndiseasereviewofliterature
AT chihfengyen outcomeandmanagementofuterineleiomyosarcomatreatedfollowingsurgeryforpresumedbenigndiseasereviewofliterature